Your browser doesn't support javascript.
loading
Neoadjuvant immunotherapy: new horizon for lymph node preservation.
Zhong, Nian-Nian; Liu, Bing; Bu, Lin-Lin.
Afiliación
  • Zhong NN; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology School & Hospital of Stomatology, Wuhan University Wuhan China.
  • Liu B; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology School & Hospital of Stomatology, Wuhan University Wuhan China.
  • Bu LL; Department of Oral & Maxillofacial-Head Neck Oncology School & Hospital of Stomatology, Wuhan University Wuhan China.
MedComm (2020) ; 5(5): e577, 2024 May.
Article en En | MEDLINE | ID: mdl-38741888
ABSTRACT
The study by Rahim et al., focusing on preoperative immunotherapy, highlights the pivotal role of CD8+ T cells within lymph nodes in response to neoadjuvant immunotherapy, suggesting that preserving lymph node integrity could bolster the treatment's efficacy by activating antitumor T cells. This underlines the importance of lymph node preservation and supports the use of immunotherapy as a neoadjuvant approach in cancer treatment.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: MedComm (2020) Año: 2024 Tipo del documento: Article Pais de publicación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: MedComm (2020) Año: 2024 Tipo del documento: Article Pais de publicación: China